Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros

Base de datos
Asunto principal
Tipo de estudio
Tipo del documento
Intervalo de año
1.
J Comp Eff Res ; 9(8): 525-526, 2020 06.
Artículo en Inglés | MEDLINE | ID: covidwho-2277597
2.
Am J Trop Med Hyg ; 2022 Nov 14.
Artículo en Inglés | MEDLINE | ID: covidwho-2119370

RESUMEN

COVID-19 underscores the need to reimagine North-South partnerships and redefine best practices for building public health and research capacity to address emergent health threats and pandemic preparedness in low- and-middle income countries (LMICs). Historically, outbreak and emergency responses have failed to ensure that the Global South has the autonomy and capacity to respond to public health threats in a timely and equitable manner. The COVID-19 response, however, has demonstrated that innovations and solutions in the Global South can not only fill resource and capacity gaps in LMICs but can also provide solutions to challenges globally. These innovations offer valuable lessons about strengthening local manufacturing capacity to produce essential diagnostic, treatment, and prevention tools; implementing high-quality research studies; expanding laboratory and research capacity; and promoting effective cooperation and governance. We discuss specific examples of capacity-building from Rwanda, South Africa, and Senegal. To fulfill promises made to the Global South during the COVID-19 pandemic, restore and resume health service delivery, and effectively prevent and respond to the next health threat, we need to prioritize equitable access to local manufacturing of basic health tools while building health systems capacities in the Global South.

3.
J Comp Eff Res ; 10(13): 957-959, 2021 09.
Artículo en Inglés | MEDLINE | ID: covidwho-1286910

RESUMEN

In this round up, we cover how COVID-19 has been beneficial for improved access to real-world data, as well as how real-world data can be used to address health inequity, an area of increasing interest for health technology assessment.


Asunto(s)
COVID-19 , Tecnología Biomédica , Humanos , SARS-CoV-2 , Evaluación de la Tecnología Biomédica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA